We are live on ! Find out more
ANAC

ANACOR PHARMACEUTICALS INC COM
ANAC

Delisted

ANAC was delisted on the 23rd of June, 2016.

Back to rankings

214 hedge funds and large institutions have $4.84B invested in ANACOR PHARMACEUTICALS INC COM in 2015 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 97 increasing their positions, 60 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

84% more call options, than puts

Call options by funds: $127M | Put options by funds: $68.9M

62% more repeat investments, than reductions

Existing positions increased: 97 | Existing positions reduced: 60

8% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 39

3% more capital invested

Capital invested by funds: $4.72B → $4.84B (+$126M)

0% more funds holding

Funds holding: 213 → 214 (+1)

11% less funds holding in top 10

Funds holding in top 10: 9 → 8 (-1)

Holders
214
Holders Change
+1
Holders Change %
+0.47%
% of All Funds
5.61%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.21%
New
42
Increased
97
Reduced
60
Closed
39
Calls
$127M
Puts
$68.9M
Net Calls
+$58M
Net Calls Change
+$23M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$299M
2
Franklin Resources
Franklin Resources
California
+$110M
3
KCM
Kingdon Capital Management
New York
+$46M
4
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$44.8M
5
Goldman Sachs
Goldman Sachs
New York
+$30.3M

Top Sellers

Rank Fund Capital Flow
1
VM
VHCP Management
New York
-$114M
2
Millennium Management
Millennium Management
New York
-$114M
3
PAI
Palo Alto Investors
California
-$43.2M
4
FCM
Farallon Capital Management
California
-$40M
5
Renaissance Technologies
Renaissance Technologies
New York
-$36.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Balyasny Asset Management
176
Balyasny Asset Management
Illinois
$243K -$403K -3,660 -63%
PAM
177
Princeton Alpha Management
New Jersey
$238K -$53.5K -486 -19%
CIM
178
Calvert Investment Management
Maryland
$234K +$228K +2,071 New
Squarepoint
179
Squarepoint
New York
$215K +$209K +1,900 New
Lazard Asset Management
180
Lazard Asset Management
New York
$196K +$30.3K +275 +19%
FAM
181
Fortaleza Asset Management
Illinois
$170K -$4.41K -40 -3%
LTFS
182
Ladenburg Thalmann Financial Services
Florida
$141K -$308K -2,799 -69%
Fifth Third Bancorp
183
Fifth Third Bancorp
Ohio
$139K +$132K +1,202 +4,293%
PAM
184
Panagora Asset Management
Massachusetts
$136K -$163K -1,479 -55%
US Bancorp
185
US Bancorp
Minnesota
$135K +$22.6K +205 +21%
Zurich Cantonal Bank
186
Zurich Cantonal Bank
Switzerland
$121K +$67.9K +616 +136%
AAM
187
Advisors Asset Management
Colorado
$120K -$291K -2,641 -71%
IA
188
IFP Advisors
Florida
$118K +$115K +1,041 New
IPC
189
Independent Portfolio Consultants
Florida
$111K +$108K +980 New
ST
190
Spot Trading
Illinois
$109K -$188K -1,707 -64%
CG
191
Cutler Group
California
$107K +$105K +950 New
JGC
192
J. Goldman & Co
New York
$106K -$3.65M -33,175 -97%
CFA
193
CT Financial Advisors
Pennsylvania
$92.6K -$55.1K -500 -38%
QT
194
Quantbot Technologies
New York
$90K +$88.4K +802 New
Pacer Advisors
195
Pacer Advisors
Pennsylvania
$76K +$73.7K +669 New
HDIM
196
Hanson & Doremus Investment Management
Vermont
$58K – – –
CHP
197
Cable Hill Partners
Oregon
$27K – – –
Victory Capital Management
198
Victory Capital Management
Texas
$23K +$22.8K +207 New
CAW
199
Cornerstone Advisors (Washington)
Washington
$14K +$13.7K +124 New
DADC
200
D.A. Davidson & Co
Montana
$13K – – –
6 7
8
9 10

ANAC Hedge Fund Activity: Q4 2015 in Review

214 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in ANACOR PHARMACEUTICALS INC COM (ANAC) for Q4 2015, worth a combined $4.84B — up 2.7% from $4.72B a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new ANAC positions and 39 closed out — a net gain of 3 holders — while 97 added to existing stakes and 60 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $299M. The largest seller was VHCP Management, cutting an estimated $114M.

  • 214 institutional investors held ANACOR PHARMACEUTICALS INC COM (ANAC) as of Q4 2015, up from 213 in Q3 2015.
  • Funds reported $4.84B of ANACOR PHARMACEUTICALS INC COM stock for Q4 2015, up 2.7% quarter-over-quarter.
  • 42 funds opened new ANACOR PHARMACEUTICALS INC COM positions in Q4 2015 and 39 closed out, a net change of +3 holders.
  • The largest ANACOR PHARMACEUTICALS INC COM buyer in Q4 2015 was Fidelity Investments, an estimated $299M added.
  • The largest ANACOR PHARMACEUTICALS INC COM seller in Q4 2015 was VHCP Management, an estimated $114M sold.

Based on aggregated 13F filings for Q4 2015.